We define equivariant asymptotic morphisms between C 0 ðX Þ-algebras and construct the category of homotopy classes of such morphisms. Based on this category we construct the category of homotopy classes of asymptotic morphisms which are equivariant with respect to an action of a groupoid. We then define and study the corresponding equivariant E-theory. r
In this mini-review, we describe some of the latest facts regarding the
generation of condensed base phonons by biological entities, initially
described by the renowned contemporary physicist, Nobel laureate, Herbert
Fr?hlich, who proposed a new biophysical interaction mechanism between
extremely high frequency electromagnetic waves and the biological
environment. As we will show, this extremely low intensity millimeter therapy
crystallizes as an important new method, universal and effective in the
management of diseases with different etiologies. Moreover, the existence of
internal electromagnetic fields generated by biological entities, as well as
external electromagnetic fields, are essential for understanding the
electromagnetic-biological effect. In fact, it is estimated that at present
millimeter-wave therapy is used for the management of more than 120 diseases
in cardiology, neurology, oncology, gynecology, urology, gastroenterology,
surgery, pharmacology and pediatrics. However, so far there is still no
consensus regarding the interaction between extremely high
frequency/extremely low intensity electromagnetic waves and the biological
environment at its different levels of organization. Thus, the present paper
was intended to contribute to the development for the theory of
millimeter-wave interaction with living biological entities.
There is increased interest in the interactions between vascular disorders
and Alzheimer?s disease (AD). While initially these interactions were
explained by the fact that these are both very common disorders, particularly
later in life, recently, the possibility that these deficiencies might
actually coexist is increasingly being questioned. This review attempts to
present modern aspects and current reports regarding the interactions between
AD, the renin-angiotensin system (RAS) and hypertension, while also
describing the relevance of antihypertensive drug use acting via the RAS in
the treatment and prevention of AD, as well as the importance of oxidative
stress, the alteration of the balance between antioxidants and pro-oxidants,
in the interaction between AD and the RAS.
Lately there is a growing interest in the negative symptoms in schizophrenia
and their mechanisms of action, with special focus on the motivation process.
The lack of motivation is increasingly recognized to be a very important
impediment to positive management in schizophrenic pathology. In this
mini-review, we described the current understanding of the nature and causes
of the specific motivational deficits in schizophrenia in order to find
better management strategies for this heterogeneous disorder. All the data
and theories presented here clearly demonstrate that amotivation is a
fundamental aspect of the negative symptomatology in schizophrenia and could
represent a useful factor in understanding and improving the mechanisms and
further management of schizophrenia.
While the exact relevance of the oxidative stress markers after the complex processes of alcohol withdrawal is still controversial, in the present report we were interested in studying the relevance of oxidative stress status in the alcohol withdrawal processes, by determining some oxidative stress markers after 3, 6 and 12 months of abstinence. 62 patients were selected, all of them males. Thus, 33 (baseline), 14 (3 months), 14 (6 months)
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.